Are GLP-1 medications HSA eligible for your situation
IRB or ethics approval is required for human studies
It remains in active Phase 3 development, with Eli Lilly targeting an NDA filing later in 2026 based on the TRIUMPH-1 and TRIUMPH-4 data reported so far
00:11:49 Vickie Danaher But theres no evidence that combos work better to improve weight loss or glycemic control, and it likely increases the risk of side effects, especially nausea, vomiting, and GI intolerance
GLP-1 plays a critical role in regulating blood sugar levels by stimulating insulin secretion from the pancreas after meals, slowing gastric emptying, and reducing appetite
These innovative treatments simultaneously target GLP-1, GIP, and glucagon pathwaysa significant advancement over current single or dual-hormone therapies